Pediatrix Medical Group, Inc.
MDHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframePart of the healthcare sector, Pediatrix Medical Group, Inc. (MD) is listed under Medical Care Facilities. With a market capitalization of $2.15B, it sits in mid-cap territory. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors.
Market Cap
$2.15B
Beta
0.66
P/E (TTM)
12.81
P/E (Fwd)
11.07
EPS (TTM)
$2.04
EPS (Fwd)
$2.36
ROE
20.9%
ROA
7.3%
Cash
$329.0M
Total Debt
$629.7M
Free CF
$163.7M
52W Change
107.9%
Annual Financials
Cash vs Debt
The company holds $329.0M in cash, though total debt stands at $629.7M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $163.7M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 20.9%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 7.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $1.97B (2022) to $1.91B (2025).
MD's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Pediatrix Medical Group, Inc.'s trajectory.